• Inicio
• h&s
• HS Dosing COSENTYX® (secukinumab)

HS Dosing COSENTYX® (secukinumab)

4.7 (576) · € 9.00 · En stock

Cosentyx: Package Insert

Systematic review of immunomodulatory therapies for hidradenitis suppurativa. - Document - Gale OneFile: Health and Medicine

Novartis gets positive opinion from CHMP for Cosentyx in adult HS

First IL-17 Inhibitor Approved in Europe for HS Patients

Cosentyx - NPS MedicineWise

FDA Approves Novartis Cosentyx® as the First New Biologic Treatment Option for Hidradenitis Suppurativa Patients in Nearly a Decade

Cosentyx 150 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)